0
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Calcium and its Regulating Hormones in Patients with Graves Disease: Sex Differences and Relation to Postoperative Tetany

, , , , , , , & show all
Pages 924-928 | Received 01 Sep 2001, Published online: 04 Dec 2011

References

  • Baxter JD, Bondy PK. Hypercalcemia of thyrotoxicosis. Ann Intern Med 1966; 65: 429–442.
  • Benucci A, Tommasi M, Fantappie B, et al. Serum 25-hydroxyvitamin D concentrations in normal subjects: seasonal variations and relationships with parathyroid hormone and osteocalcin. J Nucl Biol Med 1993; 37: 77–82.
  • Bouillon R, Muls E, De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxy-vitamin D3. J Clin Endocrinol Metab 1980; 51: 793–797.
  • Haddad JG, Chyu KJC. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endo-crinol 1971; 33: 992–995.
  • Jastrup B, Mosekilde L, Melsen F, Lund B, Lund B, Sorensen OH. Serum concentrations of vitamin D metabolites and bone remodelling in hyperthyroidism. Metabolism 1982; 31: 126–132.
  • Kobayashi T, Okano T, Shida S, et al. Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 concen-trations in human plasma obtained from 758 Japanese healthy subjects. J Nutr Sci Vitaminol 1983; 29: 271–281.
  • Krolner B, Vesterdal Jorgensen JV, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 1983: 439–446.
  • MacFarlane IA, Mawer EB, Berry J, Hann J. Vitamin D metabolism in hyperthyroidism. Clin Endocrinol 1982; 17: 51–59.
  • Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic sunscreen use decreases circulating concentra-tions of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol 1988; 124: 1802–1804.
  • Mosekilde L, Lund B, Sorensen OH, Christensen MS, Melsen F. Serum 25-hydroxycholecalciferol in hyper-thyroidism. Lancet 1977; i: 806–807.
  • Noguchi S. Subtotal thyroidectomy for Graves disease. Endocrine Surgery 1985: 321–324.
  • Ogawa Y. Mechanism of postoperative tetany in patients with hyperthyroidism. Fukushima J Med Sci 1978; 25: 65–81.
  • Parfitt AM. The incidence of hypoparathyroid tetany after thyroid operations. Relationship to age, extent of resection and surgical experience. Med J Aust 1971; 1: 1103–1107.
  • Reinhardt TA, Horst RL, Orff JVV, Hollis BW. A microas say for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984; 58: 91–98.
  • Velentzas C, Oreopoulos DG, From G, Porret B, Rapoport A. Vitamin-D concentrations in thyrotoxico-sis. Lancet 1977; i: 370–371.
  • Yamashita H, Murakami T, Noguchi S, et al. Post-operative tetany in Graves disease Important role of vitamin D metabolites. Ann Surg 1999; 229: 237–245.
  • Yamashita H, Noguchi S, Shiiba M, et al. Prediction of postoperative tetany in patients with Graves disease: a prospective study. Thyroidology Clinical Experimental 1998; 10: 293–296.
  • Yamashita H, Noguchi S, Tahara K, et al. Postoperative tetany in patients with Graves disease: a risk factor analysis. Clin Endocrinol 1997; 47: 71–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.